Abstract
Standard of Care Electronic Patient Reported Outcomes Using Promis-29 after Hematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T Cell Therapy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
